Abstract
Are short synthetic peptides the key to developing cancer vaccines? And what are the obstacles in the way?
MeSH terms
-
Antigens, Neoplasm / immunology*
-
Cancer Vaccines / immunology*
-
Humans
-
Major Histocompatibility Complex / immunology
-
T-Lymphocytes, Cytotoxic
Substances
-
Antigens, Neoplasm
-
Cancer Vaccines